Medicament Surgipharm LLP

Cresp 40 mcg Injection is a recombinant human erythropoietin (EPO) therapy used to treat anemia associated with chronic kidney disease, chemotherapy, or other conditions causing low red blood cell counts. It contains Epoetin Alfa 40 mcg, which stimulates red blood cell production, helping improve hemoglobin levels and alleviate symptoms like fatigue and weakness.

This injection is commonly prescribed for patients with chronic kidney disease, cancer patients undergoing chemotherapy, or individuals with anemia due to various medical conditions. Cresp 40 mcg Injection is administered subcutaneously or intravenously under medical supervision for safe and effective therapy.

Key Features & Benefits:

• Contains Epoetin Alfa 40 mcg, a potent erythropoietin analog.

• Helps correct anemia and increase hemoglobin levels.

• Administered SC/IV by healthcare professionals for accurate dosing.

• Reduces fatigue, weakness, and improves overall well-being.

• Ideal for patients with chronic kidney disease or chemotherapy-induced anemia.